Absent muscle fiber emerin
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Atrial Fibrillation
|
0.420 |
GeneticVariation
|
disease |
GWASCAT |
Multi-ethnic genome-wide association study for atrial fibrillation.
|
29892015 |
2018 |
Atrial Fibrillation
|
0.420 |
GeneticVariation
|
disease |
GWASDB |
Meta-analysis identifies six new susceptibility loci for atrial fibrillation.
|
22544366 |
2012 |
Atrial Fibrillation
|
0.420 |
Biomarker
|
disease |
CTD_human |
Multi-ethnic genome-wide association study for atrial fibrillation.
|
29892015 |
2018 |
Atrial Fibrillation
|
0.420 |
AlteredExpression
|
disease |
BEFREE |
The analyses in peripheral blood showed association between AF risk SNPs and decreased expression of KCNN3 (0.85-fold; p=2.1×10(-4)); and increased expression of SYNE2 (1.12-fold; p=7.5×10(-24)); however, these associations were not detectable in atrial tissue.
|
26073630 |
2015 |
Atrial Fibrillation
|
0.420 |
GeneticVariation
|
disease |
GWASCAT |
Large-scale analyses of common and rare variants identify 12 new loci associated with atrial fibrillation.
|
28416818 |
2017 |
Atrial Fibrillation
|
0.420 |
GeneticVariation
|
disease |
GWASCAT |
Biobank-driven genomic discovery yields new insight into atrial fibrillation biology.
|
30061737 |
2018 |
Atrial Fibrillation
|
0.420 |
GeneticVariation
|
disease |
BEFREE |
Genome-wide association studies (GWAS) have identified common variants in nine genomic regions associated with AF (KCNN3, PRRX1, PITX2, WNT8A, CAV1, C9orf3, SYNE2, HCN4 and ZFHX3 genes); however, the genetic variability of these risk variants does not explain the entire genetic susceptibility to AF.
|
25391453 |
2015 |
Atrial Fibrillation
|
0.420 |
GeneticVariation
|
disease |
GWASCAT |
Meta-analysis identifies six new susceptibility loci for atrial fibrillation.
|
22544366 |
2012 |
Atrial Fibrillation
|
0.420 |
Biomarker
|
disease |
CTD_human |
Meta-analysis identifies six new susceptibility loci for atrial fibrillation.
|
22544366 |
2012 |
Atrioventricular Block
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Autistic Disorder
|
0.100 |
GeneticVariation
|
disease |
GWASDB |
Individual common variants exert weak effects on the risk for autism spectrum disorders.
|
22843504 |
2012 |
Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder)
|
0.500 |
Biomarker
|
disease |
CTD_human |
|
|
|
Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder)
|
0.500 |
GermlineCausalMutation
|
disease |
ORPHANET |
|
|
|
Autosomal Recessive Emery-Dreifuss Muscular Dystrophy
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|
Back Pain
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Blepharoptosis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Cardiac Arrhythmia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Cardiomyopathies
|
0.120 |
Biomarker
|
group |
HPO |
|
|
|
Cardiomyopathies
|
0.120 |
Biomarker
|
group |
BEFREE |
Loss of the largest isoform Nesprin-2 Giant in mice is associated with a skin phenotype and altered wound healing, loss of C-terminal isoforms in mice leads to cardiomyopathies and neurological defects.
|
30220251 |
2018 |
Cardiomyopathies
|
0.120 |
GeneticVariation
|
group |
BEFREE |
To test this, we analyzed RNA-Seq datasets, finding novel isoforms or isoform tissue-specificity for: Lap2, linked to cardiomyopathy; Nesprin 2, linked to Emery-Dreifuss muscular dystrophy and Lmo7, that regulates the Emery-Dreifuss muscular dystrophy linked emerin gene.
|
29912636 |
2018 |
Cardiomyopathy, Dilated
|
0.100 |
Biomarker
|
group |
HPO |
|
|
|
Childhood Acute Lymphoblastic Leukemia
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Variants in SYNE2, MRPL47 and BAHD1 genes are putative new risk factors for VIPN in childhood acute lymphoblastic leukemia.
|
30191766 |
2018 |
Childhood onset
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Chromophobe Renal Cell Carcinoma
|
0.300 |
Biomarker
|
disease |
CTD_human |
Frequent mutations of genes encoding ubiquitin-mediated proteolysis pathway components in clear cell renal cell carcinoma.
|
22138691 |
2011 |